---
title: "Abbott’s Esprit BTK receives Health Canada approval for treating below-the-knee CLTI"
date: "2025-09-29T16:08:36.000Z"
publishedDate: "29 septembre 2025"
summary: "Health Canada has authorised the Esprit BTK everolimus-eluting resorbable scaffold system for the treatment of below-the-knee (BTK) chronic limb-threatening ischaemia (CLTI), Abbott revealed today in a press release. Until this recent Health Canada approval for the Esprit BTK system, Abbott notes that the standard of care has been balloon angioplasty."
importance: ""
sourceUrl: "https://vascularnews.com/abbotts-esprit-btk-receives-health-canada-approval-for-treating-below-the-knee-clti/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-09-29-abbotts-esprit-btk-receives-health-canada-approval-for-treating-below-the-knee-clti"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2025/09/Abbott_Stent.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/abbotts-esprit-btk-receives-health-canada-approval-for-treating-below-the-knee-clti/"
---

![Abbott’s Esprit BTK receives Health Canada approval for treating below-the-knee CLTI](https://vascularnews.com/wp-content/uploads/sites/7/2025/09/Abbott_Stent.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/abbotts-esprit-btk-receives-health-canada-approval-for-treating-below-the-knee-clti/*

## L’essentiel

Health Canada has authorised the Esprit BTK everolimus-eluting resorbable scaffold system for the treatment of below-the-knee (BTK) chronic limb-threatening ischaemia (CLTI), Abbott revealed today in a press release. Until this recent Health Canada approval for the Esprit BTK system, Abbott notes that the standard of care has been balloon angioplasty.

## Lien source

https://vascularnews.com/abbotts-esprit-btk-receives-health-canada-approval-for-treating-below-the-knee-clti/
